The relationship between Gulf war illness, brain N-acetylaspartate, and post-traumatic stress disorder

Military Medicine

Volumn 176, Issue 8, 2011, Pages 896-902

  Weiner, Michael W ^a,b   Meyerhoff, Dieter J ^a,b   Neylan, Thomas C ^a,c   Hlavin, Jennifer ^a   Ramage, Erin R ^a   McCoy, Daniel ^a,b   Studholme, Colin ^a,b   Cardenas, Valerie ^a,b   Marmar, Charles ^a,c   Truran, Diana ^a   Chu, Philip W ^b   Kornak, John ^b   Furlong, Clement E ^d   McCarthy, Charles ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DRUG DERIVATIVE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ARTICLE; BASAL GANGLION; COMORBIDITY; DRINKING BEHAVIOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PERSIAN GULF SYNDROME; PONS; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT;

ADULT; ALCOHOL DRINKING; ASPARTIC ACID; BASAL GANGLIA; COMORBIDITY; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PERSIAN GULF SYNDROME; PONS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 80051659230     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-10-00332     Document Type: Article

References (66)

1. Haley RW, Marshall WW, McDonald GG, Daugherty MA, Petty F, Fleckenstein JL: Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Radiology 2000; 215: 807-17.
2. Iversen A, Chalder T, Wessely S: Gulf War illness: lessons from medically unexplained symptoms. Clin Psychol Rev 2007; 27: 842-54.
3. Gronseth GS: Gulf War syndrome: a toxic exposure? A systematic review. Neurol Clin 2005; 23: 523-40.
4. Unwin C, Blatchley N, Coke W, et al: Health of UK servicemen who served in Persian Gulf War. Lancet 1999; 353: 169-78.
5. Engel CC, Liu X, McCarthy BD, Miller RF, Ursano R: Relationship of physical symptoms to posttraumatic stress disorder among veterans seeking care for Gulf War-related health concerns. Psychosom Med 2000; 62: 739-45.
6. McDiarmid MA, Keogh JP, Hooper FJ, et al: Health effects of depleted uranium on exposed Gulf War veterans. Environ Res 2000; 82: 168-80.
7. Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S: Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. BMJ 2000; 320: 1363-7.
8. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I: Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 1996; 2: 1382-5.
9. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL: Neurotoxicity resulting from coexposure to PB, DEET and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health 1996; 48: 35-56.
10. McCauley LA, Rischitelli G, Lambert WE, Lasarev M, Sticker DL, Spencer PS: Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq. Int J Occup Environ Health 2001; 7: 79-89.
11. Wegman DH, Woods NF, Bailar JC: Invited commentary: how would we know a Gulf War syndrome if we saw one? Am J Epidemiol 1997; 146: 704-11.
12. Ford JD, Campbell KA, Storzbach D, Binder LM, Anger WK, Rohlman DS: Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med 2001; 63: 842-9.
13. Binns JH, et al: Scientific Progress in Understanding Gulf War Veterans' Illnesses: Report and Recommendations. Research Advisory Committee on Gulf War Veterans' Illnesses. Washington, DC, Veterans Administration, 2004.
14. Miller BL: A review of chemical issues in 1H NMR spectroscopy: N-acetyl aspartate, creatine and choline. NMR Biomed 1991; 4: 47-52.
15. Haley RW, Kurt TL, Hom J: Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 1997; 277: 215-22.
16. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE: The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996; 14: 334-6.
17. Haley RW, Billecke S, La Du BN: Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999; 157: 227-33.
18. First MB, Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-IV (SCID-I). New York, NY, New York State Psychiatric Institute, Biometrics Research, 1999.
19. Hom J, Haley RW, Kurt TL: Neuropsychological correlates of Gulf War syndrome. Arch Clin Neuropsychol 1997; 12: 531-44.
20. Blake DD, Weathers FW, Nagy LM, et al: The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8: 75-90.
21. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA: Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther 1996; 34: 669-73.
22. Keane TM, Caddell JM, Taylor KL: Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: three studies in reliability and validity. J Consult Clin Psychol 1988; 56: 85-90.
23. Sobell LC, Sobell MB, Riley DM: The reliability of alcohol abusers' selfreports of drinking and life events that occurred in the distant past. J Stud Alcohol 1988; 49: 225-32.
24. Wechsler D: Wechsler Adult Intelligence Scale-III Administration and Scoring Manual. San Antonio, TX, The Psychological Corporation, 1997.
25. Tombaugh TN: Test of Memory Malingering (TOMM). New York, NY, Multi-Health Systems, 1994.
26. Conners CK,Multi-Health Systems Staff: Conners' Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual. North Tonawanda, NY, Multi-Health Systems, 2000.
27. Wechsler D: Wechsler Memory Scale, Ed 3. San Antonio, TX, The Psychological Corporation, 1997.
28. Benedict R: Brief Visuospatial Memory Test-Revised: Professional Manual. Odessa, FL, Psychological Assessment Resources, Inc., 1997.
29. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-6.
30. Corrigan JD, Hinkeldey MS: Relationships between parts A and B of the Trail Making Test. J Clin Psychol 1987; 43: 402-9.
31. Gaudino EA, Geisler MW, Squires NK: Construct validity in the Trail Making Test: what makes Part B harder? J Clin Exp Neuropsychol 1995; 17: 529-35.
32. Delis DC, Kramer JH, Kaplan E, Ober B: The California Verbal Learning Test: Research Edition. New York, NY, The Psychological Corporation, 1987.
33. Heaton RK, Grant I, Matthews CG: Comprehensive Norms for an Expanded Halstead-Reitan Battery Demographic Corrections, Research Findings, and Clinical Applications. Odessa, FL, Psychological Assessment Resources, Inc., 1991.
34. Heaton RK, Grant I, Butters N; HNRC Group: The HNRC 500- neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995; 1: 231-51.
35. Wilkinson GS: Wide Range Achievement Test-III. Administration Manual. Delaware, DE, Wide Range Inc, 1993.
36. Wetzel L, Boll TJ: Short Category Test, Booklet Format. Los Angeles, CA, Western Psychological Services, 1987.
37. Benton AB, Hamsher K: Multilingual Aphasia Examination: Word Fluency. Iowa, IA, University of Iowa Department of Neurology and Psychology, 1983.
38. Ruff RM, Light RH, Parker SB, Levin HS: Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 1996; 11: 329-38.
39. Reitan RM, Davidson LA: Clinical Neuropsychology: Current Status and Applications. Washington, DC, H. Winston, 1974.
40. Fregly AR, Smith MJ, Graybiel A: Revised normative standards of performance of men on a quantitative ataxia test battery. Acta Otolaryngol 1973; 75: 10-6.
41. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
42. Green BL: Psychometric review of the Trauma History Questionnaire (THQ). In Measurement of Stress, Trauma and Adaptation. Edited by Stamm BH. Lutherville, MD, Sidran Press, 1996.
43. Derogatis L, Lazarus L: SCL-90-R, Brief symptom inventory, and matching clinical rating scales. In The Use of Psychological Testing for Treatment Planning and Outcome Assessment, pp 217-48. Edited by Maruish ME. Hillsdale, NJ, Lawrence Erlbaum Associates, Inc., 1994
44. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
45. Kazis LE: The Veterans SF-36 Health Status Questionnaire: development and application in the Veterans Health Administration. Monitor 2000; 5.
46. Southwick SM, Morgan A, Nagy LM, et al: Trauma-related symptoms in veterans of Operation Desert Storm: a preliminary report. Am J Psychiatry 1993; 150: 1524-8.
47. Richter RJ, Furlong CE: Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999; 9: 745-53.
48. Cardenas VA, Studholme C, Meyerhoff DJ, Song E, Weiner MW: Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes. Psychiatry Res 2005; 138: 115-30.
49. Soher BJ, Young K, Bernstein A, Aygula Z, Maudsley AA: GAVA: spectral simulation for in vivo MRS applications. J Magn Reson 2007; 185: 291-9.
50. Sohe BJ, Pattany PM, Matson GB, Maudsley AA: Observation of coupled 1H metabolite resonances at long TE. Magn Reson Med 2005; 53: 1283-7.
51. Soher BJ, Young K, Govindaraju V, Maudsley AA: Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998; 40: 822-31.
52. Schuff N, Amend D, Knowlton R, Norman D, Fein G, Weiner MW: Agerelated metabolite changes and volume loss in hippocampus by proton MR spectroscopic imaging and MRI neurobiology of aging. Neurobiol Aging 1999; 20: 279-85.
53. McCulloch CE, Searle SR, Neuhaus JM: Generalized, Linear, and Mixed Models, Ed 2. Hoboken, NJ, John Wiley & Sons, Inc., 2008.
54. Binns JH, et al: Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations. Washington, DC, Department of Veterans Affairs, 2008.
55. Chao LL, Rothlind JC, Cardenas VA, Meyerhoff DJ, Weiner MW: Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans. Neurotoxicology 2010; 31: 493-501.
56. Apfel BA, Ross J, Hlavin J, et al: Hippocampal volume differences in Gulf War veterans with current versus lifetime PTSD symptoms. Biol Psychiatry 2011; 69: 541-8.
57. Ader R: Psychoneuroimmunology. Burlington, MA, Elsevier Academic Press, 2007.
58. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM: Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 2000; 42: 491-501.
59. Roy-Burne P, Smith WR, Goldberg J, Afari N, Buchwald D: Posttraumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med 2004; 34; 363-8.
60. Boscarino JA: Posttraumatic stress disorder and physical illness: results from clinical and epidemiological studies. Ann N Y Acad Sci 2004; 1032: 141-53.
61. Klooker TK, Braak B, Painter RC, et al: Exposure to severe wartime conditions in early life is associated with an increased risk of irritable bowel syndrome: a population-based cohort study. Am J Gastroenterol 2009; 104: 2250-6.
62. Weissbecker I, Floyd A, Dedert E, Slamon P, Sephton S: Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology 2006; 3: 312-24.
63. Garrison RL, Breeding PP: A metabolic basis for fi bromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 2003; 61: 182-9.
64. Pall ML: Prevalence of post-traumatic stress disorder in fi bromyalgia patients: overlapping syndromes or post-traumatic fi bromyalgia syndrome? Semin Arthritis Rheum 2001; 32: 38-50.
65. Kang HK, Natelson BH, Clare MM, Lee KY, Murphy FM: Post-traumatic stress disorder and chronic fatigue-like illness among Gulf War veterans: a population-based survey or 30,000 veterans. Am J Epidemiol 2003; 157: 141-8.
66. Lamproglou I, Barbier L, Diserbo M, Fauvelle F, Fauquette W, Amourette C: Repeated stress in combination with pyridostigmine Part 1: long-term behavioural consequences. Behav Brain Res 2009; 197: 301-10.